---
title: "Bruker Corp Pref Shares BRKRP 6.375 09/01/2028 | 8-K: FY2025 Q3 Revenue: USD 860.5 M"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/264015321.md"
published_at: "2025-11-03T12:03:43.000Z"
---

# Bruker Corp Pref Shares BRKRP 6.375 09/01/2028 | 8-K: FY2025 Q3 Revenue: USD 860.5 M

Revenue: As of FY2025 Q3, the actual value is USD 860.5 M.

EPS: As of FY2025 Q3, the actual value is USD -0.41.

EBIT: As of FY2025 Q3, the actual value is USD -31.8 M.

### Segment Revenue

-   **Bruker Scientific Instruments (BSI)**: Q3 2025 revenues were $787.9 million, a decrease of 1.5% year-over-year, with organic revenue decreasing by 5.4%.
-   **Bruker Energy & Supercon Technologies (BEST)**: Q3 2025 revenues were $73.8 million, an increase of 7.4% year-over-year, with organic revenue, net of intercompany eliminations, increasing by 6.9%.

### Operational Metrics

-   **Operating Loss**: Q3 2025 GAAP operating loss was - $51.8 million, compared to GAAP operating income of $68.1 million in Q3 2024.
-   **Non-GAAP Operating Income**: Q3 2025 non-GAAP operating income was $105.9 million, compared to $129.1 million in Q3 2024, with a non-GAAP operating margin of 12.3%, down from 14.9%.
-   **Net Income**: Q3 2025 GAAP net loss attributable to Bruker Corporation was - $62.4 million, compared to net income of $40.9 million in Q3 2024.

### Cash Flow

-   **Operating Cash Flow**: Net cash used in operating activities for Q3 2025 was - $33.2 million, compared to $38.4 million provided in Q3 2024.
-   **Free Cash Flow**: Q3 2025 free cash flow was - $54.1 million, compared to $5.8 million in Q3 2024.

### Unique Metrics

-   **Revenue Growth from Acquisitions**: Revenue growth from acquisitions contributed 1.1% to Q3 2025 revenues.

### Outlook / Guidance

-   Bruker updated its FY 2025 guidance, expecting revenues between $3.41 to $3.44 billion, with reported growth of 1-2% year-over-year and an organic decline of 4-5%. Non-GAAP EPS is expected to be between $1.85 to $1.90, down from $2.41 in FY 2024. The company anticipates significant operating margin expansion and EPS growth in 2026 due to cost-saving initiatives.

### Related Stocks

- [BRKRP.US - Bruker Corp Pref Shares BRKRP 6.375 09/01/2028](https://longbridge.com/en/quote/BRKRP.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Roadzen｜8-K：2026 財年 Q3 營收 14.36 百萬美元不及預期 |  | [Link](https://longbridge.com/en/news/275944172.md) |
| Ryan Specialty｜8-K：2025 財年 Q4 營收 7.51 億美元 |  | [Link](https://longbridge.com/en/news/275808003.md) |
| Twilio｜8-K：2025 財年 Q4 營收 13.66 億美元超過預期 |  | [Link](https://longbridge.com/en/news/275808864.md) |
| PhenixFIN｜8-K：2026 財年 Q1 營收 6.66 百萬美元 |  | [Link](https://longbridge.com/en/news/275365720.md) |
| Draftkings｜10-K：2025 財年營收 60.55 億美元超過預期 |  | [Link](https://longbridge.com/en/news/275897859.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.